Merus Announces Publication of an Abstract on Petosemtamab in Advanced Gastric/Esophageal Adenocarcinoma for Presentation at the AACR Annual Meeting 2023

(marketscreener.com) UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2023 -- Merus N.V. , a clinical-stage oncology company developing innovative, full-length multispecific antibodies , today announced the publication of an abstract for a poster presentation of early clinical data on the bispecific antibody petosemtamab in advanced...https://www.marketscreener.com/quote/stock/MERUS-N-V-27548017/news/Merus-Announces-Publication-of-an-Abstract-on-Petosemtamab-in-Advanced-Gastric-Esophageal-Adenocarci-43497071/?utm_medium=RSS&utm_content=20230414